Clinical trial of a drug for nail infection.
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients suffering from paronychia or nail infection
- Registration Number
- CTRI/2017/11/010625
- Lead Sponsor
- SK Biolabs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
Patients suffering from paronychia or nail infection
Exclusion Criteria
Healthy human volunteers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete freedom from paronychia or nail infection such as no pus, no pain, no blood, no inflammation etc.Timepoint: 2 days
- Secondary Outcome Measures
Name Time Method Complete freedom from paronychia or nail infection such as no pus, no pain, no blood, no inflammation etc.Timepoint: 15 days